Enterovirus A71 Vaccines
- PMID: 33673595
- PMCID: PMC7997495
- DOI: 10.3390/vaccines9030199
Enterovirus A71 Vaccines
Abstract
Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina. Moreover, EV-A71 infection can lead to neurological complications and death. Vaccination is the most efficient way to control virus infection. There are currently three inactivated, whole EV-A71 vaccines licensed by the China NMPA (National Medical Products Administration). Several other types of vaccines, such as virus-like particles and recombinant VP1 (capsid protein), are also under development. In this review, we discuss recent advances in the development of EV-A71 vaccines.
Keywords: Enterovirus A71; Sinovac; foot and mouth disease (HFMD); hand; vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.Hum Vaccin Immunother. 2019;15(5):1183-1190. doi: 10.1080/21645515.2019.1581539. Epub 2019 Mar 20. Hum Vaccin Immunother. 2019. PMID: 30779680 Free PMC article.
-
Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.PLoS Med. 2016 Feb 16;13(2):e1001958. doi: 10.1371/journal.pmed.1001958. eCollection 2016 Feb. PLoS Med. 2016. PMID: 26882540 Free PMC article.
-
Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.Vaccine. 2020 Feb 11;38(7):1804-1809. doi: 10.1016/j.vaccine.2019.12.025. Epub 2019 Dec 28. Vaccine. 2020. PMID: 31892446
-
Antivirals and vaccines for Enterovirus A71.J Biomed Sci. 2019 Sep 3;26(1):65. doi: 10.1186/s12929-019-0560-7. J Biomed Sci. 2019. PMID: 31481071 Free PMC article. Review.
-
Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.Rev Inst Med Trop Sao Paulo. 2018 Nov 8;60:e70. doi: 10.1590/S1678-9946201860070. Rev Inst Med Trop Sao Paulo. 2018. PMID: 30427405 Free PMC article. Review.
Cited by
-
The Bottlenecks of Preparing Virus Particles by Size Exclusion for Antibody Generation.Int J Mol Sci. 2022 Oct 26;23(21):12967. doi: 10.3390/ijms232112967. Int J Mol Sci. 2022. PMID: 36361757 Free PMC article.
-
Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3.Life (Basel). 2022 Nov 9;12(11):1832. doi: 10.3390/life12111832. Life (Basel). 2022. PMID: 36362987 Free PMC article.
-
Efficient Production of Enterovirus 71 (EV71) Virus-like Particles by Controlling Promoter Strength in Insect Cells.Viruses. 2024 May 24;16(6):834. doi: 10.3390/v16060834. Viruses. 2024. PMID: 38932128 Free PMC article.
-
Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.bioRxiv [Preprint]. 2023 Feb 2:2023.01.30.526315. doi: 10.1101/2023.01.30.526315. bioRxiv. 2023. Update in: J Gen Virol. 2023 Jun;104(6). doi: 10.1099/jgv.0.001867. PMID: 36778240 Free PMC article. Updated. Preprint.
-
EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors.Viruses. 2023 Mar 18;15(3):785. doi: 10.3390/v15030785. Viruses. 2023. PMID: 36992493 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources